2021 Q3 Form 10-Q Financial Statement

#000121465921008524 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q4
Revenue $300.0K $124.0K $80.00K
YoY Change 200.0% 65.33% -20.0%
Cost Of Revenue $114.0K $26.00K $10.00K
YoY Change 470.0% 100.0% 0.0%
Gross Profit $186.0K $98.00K $60.00K
YoY Change 132.5% 58.06% -33.33%
Gross Profit Margin 62.0% 79.03% 75.0%
Selling, General & Admin $935.0K $1.514M $1.080M
YoY Change 8.09% 196.28% 80.0%
% of Gross Profit 502.69% 1544.9% 1800.0%
Research & Development $8.000K $12.00K $10.00K
YoY Change -20.0%
% of Gross Profit 4.3% 12.24% 16.67%
Depreciation & Amortization $29.00K $35.00K $30.00K
YoY Change 45.0% 16.67% 200.0%
% of Gross Profit 15.59% 35.71% 50.0%
Operating Expenses $935.0K $1.526M $1.090M
YoY Change 8.09% 89.8% 78.69%
Operating Profit -$749.0K -$1.428M -$1.030M
YoY Change -4.59% 92.45% 98.08%
Interest Expense $8.215M $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $8.215M $70.00K
YoY Change -103.66%
Pretax Income $7.190M -$1.358M -$1.170M
YoY Change -833.67% -48.75% 88.71%
Income Tax $1.000K
% Of Pretax Income 0.01%
Net Earnings $7.189M -$1.358M -$1.170M
YoY Change -833.57% -48.81% 88.71%
Net Earnings / Revenue 2396.33% -1095.16% -1462.5%
Basic Earnings Per Share $0.99 -$0.18
Diluted Earnings Per Share $949.5K -$0.18 -$294.0K
COMMON SHARES
Basic Shares Outstanding 7.344M shares 7.392M shares
Diluted Shares Outstanding 7.571M shares 7.392M shares

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.63M $11.36M $7.940M
YoY Change 18.37% 18.35% 3076.0%
Cash & Equivalents $10.63M $11.36M $7.939M
Short-Term Investments
Other Short-Term Assets $111.0K $120.0K $180.0K
YoY Change 38.75% 140.0% 125.0%
Inventory $48.00K $54.00K $54.00K
Prepaid Expenses $120.0K $177.0K
Receivables $319.0K $143.0K $31.00K
Other Receivables $0.00 $2.952M $0.00
Total Short-Term Assets $11.11M $14.63M $8.201M
YoY Change 20.61% 50.52% 1722.44%
LONG-TERM ASSETS
Property, Plant & Equipment $215.0K $45.00K $200.0K
YoY Change -2.27% -38.36% 11.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.81M $11.00K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.49M $707.0K $573.0K
YoY Change 1989.45% 28.55% 16.94%
TOTAL ASSETS
Total Short-Term Assets $11.11M $14.63M $8.201M
Total Long-Term Assets $11.49M $707.0K $573.0K
Total Assets $22.60M $15.34M $8.774M
YoY Change 131.56% 49.35% 833.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $434.0K $423.0K $380.0K
YoY Change -19.63% 14.32% -9.52%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $434.0K $423.0K $383.0K
YoY Change -19.63% 11.32% -62.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $70.00K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $9.000K
YoY Change
Total Long-Term Liabilities $9.000K $72.00K
YoY Change -87.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $434.0K $423.0K $383.0K
Total Long-Term Liabilities $9.000K $72.00K
Total Liabilities $443.0K $423.0K $455.0K
YoY Change -28.55% -8.04% -54.95%
SHAREHOLDERS EQUITY
Retained Earnings -$70.25M -$67.67M
YoY Change
Common Stock $7.000K $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $341.0K $113.0K
YoY Change
Treasury Stock Shares 74.53K shares 7.011K shares
Shareholders Equity $22.16M $14.92M $8.319M
YoY Change
Total Liabilities & Shareholders Equity $22.60M $15.34M $8.774M
YoY Change 131.56% 49.35% 833.4%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q4
OPERATING ACTIVITIES
Net Income $7.189M -$1.358M -$1.170M
YoY Change -833.57% -48.81% 88.71%
Depreciation, Depletion And Amortization $29.00K $35.00K $30.00K
YoY Change 45.0% 16.67% 200.0%
Cash From Operating Activities -$700.0K -$768.0K -$980.0K
YoY Change 16.67% 113.33% 345.45%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$2.000K -$60.00K
YoY Change 0.0% -90.0% -68.42%
Acquisitions
YoY Change
Other Investing Activities $355.0K -$2.993M $0.00
YoY Change -100.0%
Cash From Investing Activities $335.0K -$2.995M -$60.00K
YoY Change -1775.0% 14875.0% -68.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -367.0K -234.0K 0.000
YoY Change -102.57%
NET CHANGE
Cash From Operating Activities -700.0K -768.0K -980.0K
Cash From Investing Activities 335.0K -2.995M -60.00K
Cash From Financing Activities -367.0K -234.0K 0.000
Net Change In Cash -732.0K -3.997M -1.040M
YoY Change 18.06% -145.89% 153.66%
FREE CASH FLOW
Cash From Operating Activities -$700.0K -$768.0K -$980.0K
Capital Expenditures -$20.00K -$2.000K -$60.00K
Free Cash Flow -$680.0K -$766.0K -$920.0K
YoY Change 17.24% 125.29% 2966.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39332
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Central Index Key
EntityCentralIndexKey
0001104038
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
VERIFYME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-3023677
dei Entity Address Address Line1
EntityAddressAddressLine1
Clinton Square, 75 S. Clinton Ave
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
341000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
113000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70246000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67673000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
14915000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
332000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
293000 USD
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 510
dei Entity Address City Or Town
EntityAddressCityOrTown
Rochester
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14604
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
736-9400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
VRME
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7343932 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11362000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7939000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31000 USD
CY2021Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2952000 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
120000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
177000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
54000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
54000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
14631000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8201000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
11000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
USD
CY2021Q2 vrme Finite Lived Intangible Assets Accumulated Amortization2
FiniteLivedIntangibleAssetsAccumulatedAmortization2
77000 USD
CY2020Q4 vrme Finite Lived Intangible Assets Accumulated Amortization2
FiniteLivedIntangibleAssetsAccumulatedAmortization2
50000 USD
CY2021Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
218000 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
200000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
337000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
320000 USD
CY2021Q2 vrme Finite Lived Intangible Assets Accumulated Amortization1
FiniteLivedIntangibleAssetsAccumulatedAmortization1
32000 USD
CY2020Q4 vrme Finite Lived Intangible Assets Accumulated Amortization1
FiniteLivedIntangibleAssetsAccumulatedAmortization1
20000 USD
CY2021Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
146000 USD
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
80000 USD
CY2021Q2 us-gaap Assets
Assets
15338000 USD
CY2020Q4 us-gaap Assets
Assets
8774000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
423000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
383000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
423000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
383000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
72000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
423000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
455000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
544000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
122000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1526000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
804000 USD
us-gaap Operating Expenses
OperatingExpenses
2886000 USD
us-gaap Operating Expenses
OperatingExpenses
1548000 USD
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7435005 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5603888 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7360478 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5596877 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85495000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76099000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
74527 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7011 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8319000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15338000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8774000 USD
CY2021Q2 us-gaap Revenues
Revenues
124000 USD
CY2020Q2 us-gaap Revenues
Revenues
75000 USD
us-gaap Revenues
Revenues
312000 USD
us-gaap Revenues
Revenues
167000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
26000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
13000 USD
us-gaap Cost Of Revenue
CostOfRevenue
69000 USD
us-gaap Cost Of Revenue
CostOfRevenue
30000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
98000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
62000 USD
us-gaap Gross Profit
GrossProfit
243000 USD
us-gaap Gross Profit
GrossProfit
137000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
895000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
432000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1684000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
970000 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
88000 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
68000 USD
us-gaap Professional Fees
ProfessionalFees
214000 USD
us-gaap Professional Fees
ProfessionalFees
137000 USD
CY2021Q2 vrme Payroll Expenses
PayrollExpenses
234000 USD
CY2020Q2 vrme Payroll Expenses
PayrollExpenses
225000 USD
vrme Payroll Expenses
PayrollExpenses
427000 USD
vrme Payroll Expenses
PayrollExpenses
319000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
297000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1428000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-742000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2643000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1411000 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1911000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2054000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-280000 USD
CY2021Q2 vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
70000 USD
CY2020Q2 vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
USD
vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
70000 USD
vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
70000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2573000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3745000 USD
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
23000 USD
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
50000 USD
vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
85000 USD
vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
485000 USD
vrme Fair Value Of Restricted Stock Issued For Services
FairValueOfRestrictedStockIssuedForServices
565000 USD
vrme Fair Value Of Restricted Stock Issued For Services
FairValueOfRestrictedStockIssuedForServices
99000 USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
277000 USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
USD
vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
70000 USD
vrme Payroll Protection Program Debt Forgiveness
PayrollProtectionProgramDebtForgiveness
USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
54000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-57000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1911000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
70000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2334000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1358000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2653000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2573000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3745000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7391864 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2549844 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6991690 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394948 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7391864 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2549844 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6991690 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2394948 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
569000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1007000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
365000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
688000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-280000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1992000 USD
vrme Common Stock Issued For Interest Expense
CommonStockIssuedForInterestExpense
USD
vrme Common Stock Issued For Interest Expense
CommonStockIssuedForInterestExpense
61000 USD
vrme Amortization And Depreciation Or Credit
AmortizationAndDepreciationOrCredit
55000 USD
vrme Amortization And Depreciation Or Credit
AmortizationAndDepreciationOrCredit
47000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
112000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
15000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-38000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
15989000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
350000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
149000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 USD
CY2021Q2 vrme Treasury Stockshare Repurchase
TreasuryStockshareRepurchase
-228000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1668000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-699000 USD
vrme Due From Related Parties Deposit And Prepaid Expenses On Investment
DueFromRelatedPartiesDepositAndPrepaidExpensesOnInvestment
-2937000 USD
vrme Due From Related Parties Deposit And Prepaid Expenses On Investment
DueFromRelatedPartiesDepositAndPrepaidExpensesOnInvestment
USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
55000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
29000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
45000 USD
vrme Relative Fair Value Of Common Stock Issued In Connection With2020 Debentures
RelativeFairValueOfCommonStockIssuedInConnectionWith2020Debentures
USD
vrme Relative Fair Value Of Common Stock Issued In Connection With2020 Debentures
RelativeFairValueOfCommonStockIssuedInConnectionWith2020Debentures
34000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
22000 USD
vrme Purchase Of Equity Investment
PurchaseOfEquityInvestment
11000 USD
vrme Purchase Of Equity Investment
PurchaseOfEquityInvestment
USD
us-gaap Payments For Software
PaymentsForSoftware
77000 USD
us-gaap Payments For Software
PaymentsForSoftware
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3125000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
8447000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9023000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
72000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
USD
vrme Repayment Of Bridge Financing
RepaymentOfBridgeFinancing
USD
vrme Repayment Of Bridge Financing
RepaymentOfBridgeFinancing
-750000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1747000 USD
vrme Increase In Treasury Shares Share Repurchase Program
IncreaseInTreasurySharesShareRepurchaseProgram
228000 USD
vrme Increase In Treasury Shares Share Repurchase Program
IncreaseInTreasurySharesShareRepurchaseProgram
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8216000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10092000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3423000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9342000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7939000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11362000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9595000 USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Interest Paid Net
InterestPaidNet
1000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
vrme Common Stock Issued In Relation To Conversion Of2020 Debenturesand Warrant Cancellation
CommonStockIssuedInRelationToConversionOf2020DebenturesandWarrantCancellation
USD
vrme Common Stock Issued In Relation To Conversion Of2020 Debenturesand Warrant Cancellation
CommonStockIssuedInRelationToConversionOf2020DebenturesandWarrantCancellation
1992000 USD
vrme Relative Fair Value Of Warrants Issued In Connection With2020 Debentures
RelativeFairValueOfWarrantsIssuedInConnectionWith2020Debentures
USD
vrme Relative Fair Value Of Warrants Issued In Connection With2020 Debentures
RelativeFairValueOfWarrantsIssuedInConnectionWith2020Debentures
1063000 USD
vrme Beneficial Conversion Feature In Connection With2020 Debentures
BeneficialConversionFeatureInConnectionWith2020Debentures
USD
vrme Beneficial Conversion Feature In Connection With2020 Debentures
BeneficialConversionFeatureInConnectionWith2020Debentures
650000 USD
vrme Common Stock Issued To Settle Accrued Payroll
CommonStockIssuedToSettleAccruedPayroll
USD
vrme Common Stock Issued To Settle Accrued Payroll
CommonStockIssuedToSettleAccruedPayroll
119000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
910000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
268000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
153000 USD
vrme Stock Issued During Period Value Issued For Services1
StockIssuedDuringPeriodValueIssuedForServices1
54000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10000 USD
CY2020Q2 vrme Common Stock In Relation To Conversion Of2020 Debentures Interest Expenseand Cancellation Of Warrants
CommonStockInRelationToConversionOf2020DebenturesInterestExpenseandCancellationOfWarrants
2053000 USD
vrme Stock Issued During Period Value Common Stock Issued In Relation To Public Offering Of Securities
StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities
9023000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2653000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
9818000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3779243 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1358000 USD
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7360478 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
14915000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-67000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
485000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
218000 USD
CY2020Q2 vrme Stock Issued During Period Value Issued For Services1
StockIssuedDuringPeriodValueIssuedForServices1
54000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
18000 USD
vrme Common Stock Issued In Connection With2020 Debentures
CommonStockIssuedInConnectionWith2020Debentures
66000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
650000 USD
vrme Warrants Issued In Connection With2020 Debentures
WarrantsIssuedInConnectionWith2020Debentures
1063000 USD
vrme Common Stock In Relation To Conversion Of2020 Debentures Interest Expenseand Cancellation Of Warrants
CommonStockInRelationToConversionOf2020DebenturesInterestExpenseandCancellationOfWarrants
2053000 USD
CY2020Q2 vrme Stock Issued During Period Value Common Stock Issued In Relation To Public Offering Of Securities
StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities
9023000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3745000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
9818000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7011 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8319000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
85000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
565000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
277000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23000 USD
vrme Stock Issued During Period Value Common Stock Issued In Relation To Public Offering Of Securities
StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities
8447000 USD
vrme Repurchase Of Common Stock
RepurchaseOfCommonStock
-228000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2573000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85495000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
14915000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Reclassifications
Reclassifications
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; font-weight:bold; font-style:italic; ">Reclassifications</span> </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:10pt; margin-bottom:0pt; ">Certain amounts presented for the three and six months ended June 30, 2021 reflect reclassifications made to conform to the presentation in our current reporting period. </p>
CY2021Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
5.89
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4338000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
144000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4369000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4369000 shares
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
11000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
USD
CY2021Q2 us-gaap Due From Related Parties
DueFromRelatedParties
132000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73000 USD
CY2019Q4 us-gaap Deposit Assets
DepositAssets
51000 USD
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Finite Lived Intangible Assets Cost Incurred To Renew Or Extend
FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend
77000 USD
us-gaap Finite Lived Intangible Assets Cost Incurred To Renew Or Extend
FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend
0 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000 USD
vrme Loan Forgiveness Amount
LoanForgivenessAmount
69000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3000 USD
CY2021Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
149000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
277000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
USD
CY2020Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
USD
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
74527 shares
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7011 shares
CY2021Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
341000 USD
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
113000 USD
vrme Unrecognized Compensation Cost
UnrecognizedCompensationCost
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3779243 shares
CY2020Q4 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
5.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y6M
CY2021Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
3779243 shares
CY2021Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
5.89
vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms
P3Y6M
CY2021Q2 vrme Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1
USD

Files In Submission

Name View Source Status
0001214659-21-008524-index-headers.html Edgar Link pending
0001214659-21-008524-index.html Edgar Link pending
0001214659-21-008524.txt Edgar Link pending
0001214659-21-008524-xbrl.zip Edgar Link pending
ex10_1.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrme-20210630.xsd Edgar Link pending
vrme-20210630_cal.xml Edgar Link unprocessable
vrme-20210630_def.xml Edgar Link unprocessable
vrme-20210630_lab.xml Edgar Link unprocessable
vrme-20210630_pre.xml Edgar Link unprocessable
vrme10q0621.htm Edgar Link pending
vrme10q0621_htm.xml Edgar Link completed